EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis

Luz Angela Torres-de la Roche iD, Angélica Acevedo-Mesa, Ingrid Lizeth Lizarazo, Rajesh Devassy, Sven Becker, Harald Krentel iD, Rudy Leon De Wilde iD

Cancers · 28.11.2023 · 15 (23) · 5624

DOI: 10.3390/cancers15235624 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.11.2023. Verfasst von Luz Angela Torres-de la Roche und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital for Gynecology, Pius Hospital, University Medicine Oldenburg, Carl von Ossietzky University, 26121 Oldenburg, Germany. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to summarize evidence from observational studies about the lifetime use of HC and the risk of BC in women of reproductive age. The PubMed, Cochrane, and EMBASE databases were searched for observational studies published from 2015 to February 2022. Meta-analyses were performed using adjusted odds ratios and relative risks with a random-effects model using the I2 statistic to quantify the heterogeneity among studies. Of the 724 studies identified, 650 were screened for title/abstract selection, 60 were selected for full-text revision, and 22 were included in the meta-analysis. Of these, 19 were case-control studies and 3 were cohort studies. The results of the meta-analysis indicate a significantly higher risk of developing BC in ever users of HC (pooled OR = 1.33; 95% CI = 1.19 to 1.49). This effect is larger in the subgroups of case-control studies (pooled OR = 1.44, 95% CI = 1.21 to 1.70) and in the subgroup of studies that strictly define menopausal status (pooled OR = 1.48; 95% CI, 1.10 to 2.00). Although our meta-analysis of observational studies (cohort and case-control) suggests a significantly increased overall risk of BC in users or ever-users of modern hormonal contraceptives, the high heterogeneity among studies (>70%) related to differences in study design, measurement of variables, confounders, among other factors, as well as publication biases should be considered when interpreting our results.

Schlagwörter

Stichwörter der Autor:innen

breast cancerhormonal contraceptionmeta-analysispremenopausalrisk factors

Autor:innen und Institutionen

  • University Hospital for Gynecology, Pius Hospital, University Medicine Oldenburg, Carl von Ossietzky University, 26121 Oldenburg, Germany.
  • University Hospital for Gynecology and Obstetrics, University Hospital Frankfurt, 60596 Frankfurt, Germany.
  • Clinic of Gynecology, Obstetrics, Oncology, and Senology, Bethesda Hospital, 47053 Duisburg, Germany.

ORCID-Profile: Luz Angela Torres-de la Roche, Harald Krentel, Rudy Leon De Wilde

Zitieren

APA

Torres-de la Roche, L. A., Acevedo-Mesa, A., Lizarazo, I. L., Devassy, R., Becker, S., Krentel, H., & De Wilde, R. L. (2023). Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis. Cancers, 15(23), 5624. https://doi.org/10.3390/cancers15235624

Vancouver

Torres-de la Roche LA, Acevedo-Mesa A, Lizarazo IL, Devassy R, Becker S, Krentel H, et al. Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis. Cancers. 2023;15(23):5624. doi:10.3390/cancers15235624

BibTeX
@article{TorresdelaRoche2023,
  author = {Torres-de la Roche, Luz Angela and Acevedo-Mesa, Angélica and Lizarazo, Ingrid Lizeth and Devassy, Rajesh and Becker, Sven and Krentel, Harald and De Wilde, Rudy Leon},
  title = {Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {23},
  pages = {5624},
  doi = {10.3390/cancers15235624}
}
Kostenlos starten →